Viewing Study NCT02860650


Ignite Creation Date: 2025-12-24 @ 5:18 PM
Ignite Modification Date: 2026-01-16 @ 9:33 AM
Study NCT ID: NCT02860650
Status: COMPLETED
Last Update Posted: 2018-02-05
First Post: 2016-08-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Safety, Tolerability, and Immunogenicity of Heterologous Prime-boost Regimens Using the Multivalent Filovirus Vaccines Ad26.Filo and MVA-BN-Filo Administered in Different Sequences and Schedules in Healthy Adults
Sponsor: Janssen Vaccines & Prevention B.V.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module